25 results
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Myelodysplastic ... • Risks: infection ... only curative treatment ... #treatment #hematology ... #oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... patients at high risk ... of recurrent VTE ... Anticoagulation #Management ... #Hematology #Oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the treatment ... body mass index; VTE ... Anticoagulation #Management ... #Hematology #Oncology
Myelodysplastic Syndromes (MDS)

What?
Myelodysplastic syndromes are a group of disorders caused by blood cells that are poorly
carries a variable risk ... factor (GCSF) treatments ... marrow studies Treatment ... and reducing the risk ... diagnosis #hematology #oncology
Rewarming Methods in Hypothermia
 • Passive rewarming - Requires adequate patient physiologic mechanisms. Inadequate for more
Low benefit, low risk ... Gastric lavage - Risks ... Thoracic lavage - Risks ... #Hypothermia #management ... #treatment #ebm
Treatment Schema for Standard-Risk Acute Lymphoblastic Leukemia
Induction: 
 • Vincristine, Steroid (dexamethasone), L-Asparaginase, Intrathecal (IT) methotrexate
Consolidation
Treatment Schema ... for Standard-Risk ... given throughout treatment ... #timeline #oncology ... pediatrics #peds #management
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
Toxic injury to BM ... • Hypocellular myelodysplastic ... aplastic anemia Treatment ... Aplastic #Anemia #oncology ... hematology #diagnosis #management
Aortic Dissection - Diagnosis and Management Summary
 • HPI: sudden onset, "tearing" chest pain, radiation to
Diagnosis and Management ... stroke-like symptoms • Risk ... Type B = medical management ... - MH/CCF/CWRU EM ... #summary #treatment
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... Other hardware - Risk-Benefit ... Generally no routine TTE ... IDSA #Guidelines #Management ... #candidiasis #treatment
Post-Transplantation Lymphoproliferative Disorders (PTLD)
Definition: Lymphoid and/or plasmacytic proliferations that occur as a result of immunosuppression in
immunocompetent population Risk ... liver>kidney), EBV ... ↑ LDH), rising EBV ... Lymphoproliferative #Disorders #oncology ... #diagnosis #management